In Conversation,
research for pharmacists

Overview

In conversation with different members of the Learning Rheum steering committee, each episode in this series explores how pharmacists can get involved in research to improve services for patients. Including guidance on the steps involved to design, deliver, and publish research, with valuable practical advice and personal experience shared along the way. 

Podcast 1

In conversation, how to get involved in research

In conversation with a health journalist, hear from a member of the Learning Rheum steering committee, Lewis Sutherland, Senior Clinical Rheumatology Pharmacist. In three chapters, the podcast explores how pharmacists can get involved in research to support patient-centred care. Lewis offers valuable practical advice on the steps involved with examples from his own personal experience in research.  

 
Chapter 1: Why research?

Learn why you should consider getting involved in research to better support your patients and advance your professional development.

Job code: GB-RA-NA-202207-00020 
Date of preparation: September 2022

 
Chapter 2: Research types

Find out about the different types of research you can get involved in and learn from Lewis Sutherland’s own experience to get inspired. 

Job code: GB-RA-NA-202207-00023 
Date of preparation: September 2022

 
Chapter 3: How to get started

Are you interested to get involved in research but don’t know how to get started? Lewis Sutherland explains the steps involved and offers personal advice to support your journey into research.

Job code: GB-RA-NA-202207-00024 
Date of preparation: September 2022

Supporting materials

Contributor bio

Lewis Sutherland
Senior Clinical Pharmacist – Rheumatology 

Lewis has experience across primary and secondary care, with his previous role being a senior clinical pharmacist in Osteoporosis and Population Health, and now being a senior clinical pharmacist in Rheumatology.  Through this he is involved in research, education, CMDU, and treatment/governance decisions relating to biologic and targeted synthetic DMARDs.

GB-RA-NA-202210-00005  | Date of preparation: December 2022